• 中文 | CN

Don’t Miss WuXi TIDES at TIDES USA, May 19-22

Join us in booth #807 at The Manchester Grand Hyatt San Diego and discover how our integrated CDMO platform can accelerate your path from preclinical to commercial.

Let’s connect and explore how we enable our customers to discover, develop and manufacture their small molecules and bring life-changing therapies to patients—faster and more efficiently.

We move fast, so you can move forward. 

TIDES USA 807 TIDES-USA

Innovating Together: Must-Attend Events

We’re proud to sponsor and participate in some of the most exciting and impactful events during TIDES USA 2025. Join us as we connect, collaborate, and drive innovation in drug development and manufacturing. Stay tuned for more details—you won’t want to miss it!

1

Networking Reception

5:00 pm 
Tuesday, May 20
Poster and Exhibit Halls (Grand Ballroom and Harbor Ballroom)

2

WuXi TIDES Spotlight Presentation

7:45 am 
Wednesday, May 21
Topic: Bridging the Translational Chasm in Oligonucleotide/Peptide Programs 

Join Us To Find Out More About Bridging the Translational Chasm in Oligonucleotide/Peptide Programs: A Convergence Framework in Propelling Novel Modalities from Lead Optimization to GMP Readiness

The translation of complex therapeutics from discovery to development presents unique hurdles for innovators. Emerging modalities like oligonucleotides and peptides face a 73% attrition rate in early development (Nature Reviews Drug Discovery, 2023), driven by critical bottlenecks in:

  1. Structural Fidelity – Ensuring pharmacophore integrity through scale-up
  2. Impurity Snowball Effect – Uncontrolled process-related variants leading impurity accumulation beyond thresholds
  3. Manufacturing Discontinuity –Knowledge gaps between discovery synthesis and GMP production

Through anonymized case studies of clinical-stage programs, this talk will dissect how integrated technical strategies can address these translational cliffs, and how a cross-functional convergence framework, where medicinal chemistry insights and process science fundamentals strategically align, enables synchronized progression of oligonucleotide/peptide candidates.

Why WuXi TIDES?

A Fully Integrated CRDMO Platform

Discovery, development and the entire manufacturing supply chain for TIDES molecules in one world-class organization

Unrivaled Speed and Quality

IND-Enabling CMC packages delivered in as little as 11 months, 7 PPQ campaigns successfully completed in 7 months.

Unparalleled Scale

41,490 L solid-phase peptide synthesizer total reactor volume, expanding to over 100,000 L by the end of 2025. 1,400+ scientists dedicated to oligonucleotide and peptide development.

Commitment to Quality and Compliance

All sites operate under a unified global quality system, with a proven track record of surpassing regulatory standards worldwide

What is TIDES USA all about? 

The TIDES USA conference, takes place from May 19-22, 2025, it’s a dynamic gathering that brings together experts from the biopharmaceutical industry to explore the latest innovations in drug development and delivery. It dives into cutting-edge technologies, the future of biologics, and novel treatments while also addressing key topics like regulatory challenges, manufacturing advancements, and the scaling of new therapies. 

You will have the opportunity to network with industry leaders, discover breakthrough solutions, and discuss emerging trends that are shaping the future of healthcare. It’s a hub for collaboration, knowledge-sharing, and exploring new ways to improve patient outcomes through biopharma innovation.

Join us at Upcoming Events!

From cutting-edge scientific presentations to expert-led discussions on industry trends, each event offers an unique opportunity to network, gain insights, and collaborate on the future of biotech innovation.

Ready to speak about your next project?

Scroll to Top
Please enable JavaScript in your browser to complete this form.
Checkboxes